U.S. Patent Disclosures
Friday, April 13, 2012
Ariad Pharmaceuticals Inc., of Cambridge, Mass., received U.S. Patent No. 8,114,874, titled "Substituted Acetylenic Imidazo[1,2-B] Pyridazine Compounds as Kinase Inhibitors." It provides composition-of-matter protection for investigational pan-Bcr-Abl inhibitor ponatinib.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.